Press Releases on January 8, 2024 - EIN Presswire - Press Release Distribution Service

Published on January 8, 2024 - 13:34 GMT

Stereotaxis Announces First Patients Successfully Treated Using MAGiC Ablation Catheter

ST. LOUIS, Jan. 08, 2024 (GLOBE NEWSWIRE) -- Stereotaxis (NYSE: STXS), a pioneer in surgical robotics for minimally invasive endovascular intervention, today announced that the first patients have been successfully treated using its Magnetic Interventional …

Distribution channels: Healthcare & Pharmaceuticals Industry ...

Published on January 8, 2024 - 13:34 GMT

FDA warns about dental problems with buprenorphine medicines dissolved in the mouth to treat opioid use disorder and pain

A search of the FDA Adverse Event Reporting System (FAERS) database and the medical literature1,2 through December 31, 2018, identified 305 cases of dental adverse events reported with transmucosal buprenorphine use. Patients with opioid use disorder (OUD …

Distribution channels: Healthcare & Pharmaceuticals Industry

Published on January 8, 2024 - 13:34 GMT

FDA approval of lymphoma medicine Ukoniq (umbralisib) is withdrawn due to safety concerns

Possible increased risk of death outweighs the benefits Español Drug Safety Podcast 6-1-2022 FDA Drug Safety Communication Drug Safety Communication (PDF - 197 KB) Due to safety concerns, the U.S. Food and Drug Administration (FDA) has withdrawn its …

Distribution channels: Healthcare & Pharmaceuticals Industry

Published on January 8, 2024 - 13:34 GMT

FDA recommends thyroid monitoring in babies and young children who receive injections of iodine-containing contrast media for ...

Since 2015 when FDA first alerted the public about cases of underactive thyroid in infants receiving iodinated contrast media (ICM), several research studies evaluating this risk have been published.1-6 We reviewed these six studies and the five earlier …

Distribution channels: Healthcare & Pharmaceuticals Industry

Published on January 8, 2024 - 13:34 GMT

FDA requests removal of strongest warning against using cholesterol-lowering statins during pregnancy; still advises most pregnant ...

FDA reviewed data from case series and prospective and retrospective observational cohort studies over decades of use of statins in pregnant women.1-15 Multiple larger, well-designed, and controlled observational studies did not find an increase in major …

Distribution channels: Healthcare & Pharmaceuticals Industry

Published on January 8, 2024 - 13:34 GMT

FDA requires warnings about increased risk of serious heart-related events, cancer, blood clots, and death for JAK inhibitors that ...

When FDA first approved Xeljanz (tofacitinib), we required the manufacturer, Pfizer, to conduct a randomized safety clinical trial in patients with rheumatoid arthritis (RA) who were taking methotrexate to evaluate the risk of cardiovascular events, …

Distribution channels: Healthcare & Pharmaceuticals Industry

Published on January 8, 2024 - 13:34 GMT

FDA requiring Boxed Warning updated to improve safe use of benzodiazepine drug class

We reviewed postmarketing databases and the published literature on the use of benzodiazepines and associated abuse, misuse, addiction, and physical dependence. In 2019, an estimated 92 million benzodiazepine prescriptions were dispensed from U.S …

Distribution channels: Healthcare & Pharmaceuticals Industry

Published on January 8, 2024 - 13:34 GMT

FDA removes Boxed Warning about risk of leg and foot amputations for the diabetes medicine canagliflozin (Invokana, Invokamet, ...

Español Drug Safety Podcast 8-26-2020 FDA Drug Safety Communication Drug Safety Communication (PDF - 58KB) Based on a U.S. Food and Drug Administration (FDA) review of new data from three clinical trials, we have removed the Boxed Warning about amputation …

Distribution channels: Healthcare & Pharmaceuticals Industry

Published on January 8, 2024 - 13:34 GMT

FDA recommends health care professionals discuss naloxone with all patients when prescribing opioid pain relievers or medicines to ...

To reduce the risk of death from opioid overdose, the U.S. Food and Drug Administration (FDA) is making the following recommendations about the opioid reversal medicine, naloxone: For all patients who are prescribed opioid pain relievers, health care …

Distribution channels: Healthcare & Pharmaceuticals Industry

Published on January 8, 2024 - 13:34 GMT

FDA requires Boxed Warning about serious mental health side effects for asthma and allergy drug montelukast (Singulair); advises ...

We reviewed case reports submitted to FDA, conducted an observational study using data from FDA’s Sentinel System, and reviewed observational and animal studies in the published literature. We evaluated reporting trends for all neuropsychiatric adverse …

Distribution channels: Healthcare & Pharmaceuticals Industry

Published on January 8, 2024 - 13:32 GMT

Drug Trials Snapshots: VEOPOZ

HOW TO USE THIS SNAPSHOT The information provided in Snapshots highlights who participated in the key clinical trials that supported the original FDA approval of this drug, and whether there were differences among sex, race, age, and ethnic groups. The “ …

Distribution channels: Healthcare & Pharmaceuticals Industry

Published on January 8, 2024 - 13:31 GMT

Yield10 Bioscience Files Request for Regulatory Status Review with USDA-APHIS for Camelina Designed to Produce the EPA and DHA ...

WOBURN, Mass., Jan. 08, 2024 (GLOBE NEWSWIRE) -- Yield10 Bioscience, Inc. (Nasdaq:YTEN) (“Yield10” or the “Company”), an agricultural bioscience company, today announced that the Company recently filed a request for a Regulatory Status Review (“RSR”) with …

Distribution channels: Media, Advertising & PR, Technology ...

Published on January 8, 2024 - 13:31 GMT

Wikipedia Erases History: Melbourne Shuffle Creator Maurice Novoa Disappears from Wiki Void

MELBOURNE, VICTORIA, AUSTRALIA, January 8, 2024 /⁨EINPresswire.com⁩/ -- In a grim twist of events, the dance floor legacy of Melbourne Shuffle and its self-proclaimed creator, Maurice Novoa, has succumbed to the dark and censorial forces at play within …

Distribution channels: Music Industry ...

Published on January 8, 2024 - 13:31 GMT

Wasseem Dirani's 2024 Outlook for the Economy

Wasseem Dirani's 2024 Outlook for the Economy HAMILTON, ONTARIO, CANADA, January 8, 2024 /⁨EINPresswire.com⁩/ -- Wasseem Dirani believes Canada's economic trajectory in 2024 is likely to be influenced by a confluence of global and domestic factors …

Distribution channels: Banking, Finance & Investment Industry, Building & Construction Industry ...

Published on January 8, 2024 - 13:30 GMT

Standard BioTools Announces Preliminary Fourth Quarter and Full Year 2023 Revenue

SOUTH SAN FRANCISCO, Calif., Jan. 08, 2024 (GLOBE NEWSWIRE) -- Standard BioTools Inc. (Nasdaq: LAB) (Standard BioTools or the Company), driven by a bold purpose – Unleashing tools to accelerate breakthroughs in human health, today announced Standard …

Distribution channels: Business & Economy, Healthcare & Pharmaceuticals Industry ...

Published on January 8, 2024 - 13:30 GMT

USAN Approves Generic Name “Ruxoprubart” for NM8074, an Antibody Therapy focused on Complement-Mediated Diseases

CLEVELAND, OH, UNITED STATES, January 8, 2024 /⁨EINPresswire.com⁩/ -- NovelMed, a clinical-stage biopharmaceutical company with expertise in inflammatory and complement-related diseases, is pleased to announce that the United States Adopted Name (USAN) …

Distribution channels: Business & Economy, Companies ...

Published on January 8, 2024 - 13:30 GMT

Community Hospital Partners with mTuitive for Synoptic Reporting and Pilots Oncology Data Engine

mTuitive Solutions Support Hospital’s Reporting and Accreditation Compliance CENTERVILLE, MA, UNITED STATES, January 8, 2024 /⁨EINPresswire.com⁩/ -- Community Hospital in Grand Junction Colorado has recently partnered with mTuitive to integrate the …

Distribution channels: Business & Economy, Healthcare & Pharmaceuticals Industry ...

Published on January 8, 2024 - 13:30 GMT

TiniFiber® Launches Certified Installer Program Backed by 25-Year Warranty

Program for select installers elevates connectivity standards for reliability and peace of mind LINDENHURST, NEW YORK, USA, January 8, 2024 /⁨EINPresswire.com⁩/ -- TiniFiber®, the exclusive manufacturer of U.S. patented and UL-approved TiniFiber® Micro …

Distribution channels: Companies, Conferences & Trade Fairs ...

Published on January 8, 2024 - 13:30 GMT

Evaxion Announces Plan to Implement ADS Ratio Change

COPENHAGEN, Denmark, Jan. 08, 2024 (GLOBE NEWSWIRE) -- Evaxion Biotech A/S (NASDAQ: EVAX) (“Evaxion” or the “Company”), a clinical-stage TechBio company specializing in developing AI-Immunology™ powered vaccines, today announced that it plans to change …

Distribution channels: Technology ...

Published on January 8, 2024 - 13:30 GMT

Soft Magnetic Composite Market Valuation to Reach US$ 108,392.0 Million by 2033 Amid Rising Demand from Ancillary Industries | ...

NEWARK, Del, Jan. 08, 2024 (GLOBE NEWSWIRE) -- According to a Future Market Insights (FMI) report, the global soft magnetic composite market value is forecast to increase from US$ 44,459.0 Million in 2023 to US$ 108,392.0 Million by 2033. Over the …

Distribution channels: Book Publishing Industry ...